<?xml version="1.0" encoding="UTF-8"?>
<fig id="F0009" orientation="portrait" position="float">
 <label>Figure 9.</label>
 <caption>
  <p>Protective effects of the anti-CVA4 serum. The 3-day-old neonatal mice (
   <italic>n </italic>= 10–15) were challenged with a lethal dose of YT226R. The neonatal mice with a clinical score of 1–2 were treated with the antisera diluted at a ratio of 1:1, 1:10, 1:100 and 1:1000 twice (Early stage treatment). Also, the neonatal mice with a clinical score of ≥3 were treated with the antisera twice (Late stage treatment).
  </p>
 </caption>
 <graphic xlink:href="TEMI_A_1673135_F0009_OC" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
